在患有喘和高体脂百分比的患者中增加氧化应激和类固醇不敏感性
Masako To1, Yoshihito Arimoto2, Natsue Honda2
1Department of Laboratory Medicine, Dokkyo Medical University, Saitama Medical Center, Saitama, Japan; Department of Respiratory Medicine, The Fraternity Memorial Hospital, Tokyo, Japan.
概括
喘患者的高体脂百分比与降低类固醇敏感性有关,可能是由于氧化应激. 甲胺可以通过降低这种氧化压力来改善类固醇反应能力.
科学领域:
- 肺部医学 肺部医学
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
背景情况:
- 肥胖是喘控制不良和皮质类固醇反应降低的已知的危险因素.
- 身体脂肪百分比可能是比BMI更重要的肥胖相关疾病指标.
- 身体脂肪百分比对喘和类固醇敏感性的特定影响需要进一步调查.
研究的目的:
- 检查喘患者体脂肪百分比与类固醇敏感性之间的关联.
- 探索连接身体脂肪百分比,喘和类固醇耐药性的潜在机制.
- 评估甲福明在改善类固醇敏感性的潜力.
主要方法:
- 成年喘患者被分为高体脂 (HBF) 和对照组.
- 使用外周血液单核细胞来评估德克萨梅他的抑制度 (IC50-Dex).
- 分析了血清脂肪基因,氧化应激标志物,以及甲胺对类固醇敏感性的影响.
主要成果:
- 在HBF组显示显著更高的IC50-Dex值,表明降低了类固醇敏感性.
- 在HBF组中,IC50-Dex与恶化频率和氧化应激标志物相关.
- 在HBF组中,甲福明治疗降低了IC50-Dex和氧化应激标志物.
结论:
- 增加的身体脂肪和相关的氧化压力可能会损害喘中的类固醇敏感性.
- 甲福明通过减轻氧化压力,显示出增强类固醇敏感性的潜力.
- 这表明甲福明是喘患者高体脂的可能治疗策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
298
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
298
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
204
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
204
Obesity
356
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
356


